Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice
- PMID: 25487733
- DOI: 10.1016/j.parkreldis.2014.11.007
Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice
Abstract
Background: Accurate diagnosis of Parkinson disease (PD) and other degenerative parkinsonian syndromes is important for management and prognostic purposes. Diagnosis can be challenging in early disease and in atypical cases.
Methods: We reviewed the literature on the application of dopamine transporter single-photon emission computed tomography (DAT-SPECT) in degenerative parkinsonism and related disorders as a diagnostic tool.
Results: The use of DAT-SPECT shows some utility in the early diagnosis of PD and differentiation from other non-degenerative parkinsonian disorders (i.e. essential tremor, dystonic tremor, drug-induced and in most cases of psychogenic parkinsonism), since it can accurately detect the presynaptic dopaminergic deficit. The test has been shown to have high sensitivity/specificity by multiple studies. DAT imaging may also have some prognostic value for disease progression. However, it has limited value in differentiating among degenerative causes of parkinsonism. DAT imaging has some limitations. In most studies, true test accuracy is unknown since the gold standard is clinical diagnosis by a movement disorders neurologist. Therefore, the sensitivity of the test cannot exceed that of the clinical diagnosis. In addition, false negative scans occur and highlight the need for clinical follow-up.
Conclusion: Clinical assessment remains the most important aspect in evaluating these patients. DAT-SPECT is a sensitive modality to detect nigrostriatal degeneration. In spite of increasing data using this technique, however, more long-term clinical studies are required to determine how DAT-SPECT scan can guide decision-making.
Keywords: Dopamine transporter; Parkinson's disease; Parkinsonism; SPECT; Tremor.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
-
The role of DAT-SPECT in movement disorders.J Neurol Neurosurg Psychiatry. 2010 Jan;81(1):5-12. doi: 10.1136/jnnp.2008.157370. J Neurol Neurosurg Psychiatry. 2010. PMID: 20019219 Review.
-
Neuropathologic Validation and Diagnostic Accuracy of Presynaptic Dopaminergic Imaging in the Diagnosis of Parkinsonism.Neurology. 2024 Jun 11;102(11):e209453. doi: 10.1212/WNL.0000000000209453. Epub 2024 May 17. Neurology. 2024. PMID: 38759132
-
Role of DAT-SPECT in the diagnostic work up of parkinsonism.Mov Disord. 2007 Jul 15;22(9):1229-38. doi: 10.1002/mds.21505. Mov Disord. 2007. PMID: 17486648 Review.
-
Dopamine transporter SPECT imaging in Parkinson’s disease and parkinsonian disorders.Turk J Med Sci. 2021 Apr 30;51(2):400-410. doi: 10.3906/sag-2008-253. Turk J Med Sci. 2021. PMID: 33237660 Free PMC article. Review.
-
Impact of DAT-SPECT on Management of Patients Suspected of Parkinsonism.Clin Nucl Med. 2018 Oct;43(10):710-714. doi: 10.1097/RLU.0000000000002240. Clin Nucl Med. 2018. PMID: 30153144
Cited by
-
Biophysical Modeling of Dopaminergic Denervation Landscapes in the Striatum Reveals New Therapeutic Strategy.eNeuro. 2022 Mar 3;9(2):ENEURO.0458-21.2022. doi: 10.1523/ENEURO.0458-21.2022. Print 2022 Mar-Apr. eNeuro. 2022. PMID: 35165198 Free PMC article.
-
MIBG Myocardial Scintigraphy Identifies Premotor PD/DLB During a Negative DAT Scan Period: Second Report.Mov Disord Clin Pract. 2018 Nov 9;6(1):46-50. doi: 10.1002/mdc3.12697. eCollection 2019 Jan. Mov Disord Clin Pract. 2018. PMID: 30746415 Free PMC article.
-
Neuroimaging in Functional Movement Disorders.Curr Neurol Neurosci Rep. 2019 Feb 12;19(3):12. doi: 10.1007/s11910-019-0926-y. Curr Neurol Neurosci Rep. 2019. PMID: 30747347 Free PMC article. Review.
-
Hand Tremor Questionnaire: A Useful Screening Tool for Differentiating Patients with Hand Tremor between Parkinson's Disease and Essential Tremor.J Clin Neurol. 2018 Jul;14(3):381-386. doi: 10.3988/jcn.2018.14.3.381. J Clin Neurol. 2018. PMID: 29971978 Free PMC article.
-
Peripheral Synucleinopathy in Early Parkinson's Disease: Submandibular Gland Needle Biopsy Findings.Mov Disord. 2016 Feb;31(2):250-6. doi: 10.1002/mds.26476. Epub 2016 Jan 22. Mov Disord. 2016. PMID: 26799362 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical